BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
The text from her son Randy that Heather Bacchus received at at 1:26 AM on July 17, 2021, seemed like good news. “I’m quitting weed for good and want to surround myself with healthy and happy people,” he wrote. “This has been too much for me and for you guys.” Less than an hour later,
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Published online by Cambridge University Press: 04 May 2023 Carsten Hjorthøj[, Wilson Compton, Marie Starzer, Dorte Nordholm ,Emily Einstein, Annette Erlangsen, Merete Nordentoft ,Nora D. Volkow and Beth Han Abstract Background Previous research suggests an increase in schizophrenia population attributable risk fraction (PARF) for cannabis use disorder (CUD). However, sex and age variations in CUD and schizophrenia
Long ago, the THC content of weed was less than 1.5%. Today some marijuana products have more than 90%. It’s making people sick, and regulators have failed to keep up. Marijuana and other products containing THC, the plant’s main psychoactive ingredient, have grown more potent and more dangerous as legalization has made them more widely available.
Edoardo Spinazzola1,* , Diego Quattrone2,3,4,* , Victoria Rodriguez1, Giulia Trotta2 , Luis Alameda1,5,6 , Giada Tripoli1,7 ,Charlotte Gayer-Anderson8 , Tom P Freeman9,10, Emma C Johnson11, Hannah E Jongsma12, Simona Stilo1,13, Caterina La Cascia7, Laura Ferraro7, Daniele La Barbera7, Antonio Lasalvia14, Sarah Tosato14, Ilaria Tarricone15, Giuseppe D’Andrea15, Michela Galatolo15, Andrea Tortelli16,17,Ilaria Tagliabue18,19, Marco Turco18, Maurizio Pompili20,
NIH study highlights the need to proactively screen for, prevent, and treat cannabis use disorder, especially among young people May 4, 2023 ©Getty Images/Nikola Stojadinovic Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
The IASIC board of directors would like to thank our Expert Physician Council, Expert Affiliate Council and Donors for your support in creating IASIC and contributing to a successful first year. We could not have achieved what we did without you. A heartful thank you to all of you as we reflect on 2022 and share
CNN – In just five years, the number of small children in the US exposed to cannabis after accidentally eating an edible rose 1,375%, a new study says. There were more than 7,040 exposures to edible cannabis in kids under 6 between 2017 and 2021, according to an analysis of records from the National Poison Data
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
